ABVC BioPharma, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2021
Total Assets: $13.7M
Liabilities Breakdown FY2021
Total Liabilities: $4.8M
Asset Breakdown
Total Assets: $13.7M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $5.8M | 42.6% |
| Accounts Receivable | $280.7K | 2.0% |
| Inventory | $26.0K | 0.2% |
| Property, Plant & Equipment | $525.9K | 3.8% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $7.0M | 51.4% |
Liabilities Breakdown
Total Liabilities: $4.8M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $0 | 0.0% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $4.8M | 100.0% |